Ameritas Advisory Services, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 61 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ameritas Advisory Services, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$64,579
-31.9%
44,232
-2.4%
0.01%
+60.0%
Q1 2023$94,856
+85.3%
45,3020.0%0.01%
+150.0%
Q4 2022$51,191
-30.8%
45,3020.0%0.00%
-50.0%
Q3 2022$74,000
+25.4%
45,3020.0%0.00%
+33.3%
Q2 2022$59,000
-16.9%
45,302
+2.4%
0.00%0.0%
Q1 2022$71,000
-22.8%
44,2320.0%0.00%0.0%
Q4 2021$92,00044,2320.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 169,578$222,0000.08%
Geneos Wealth Management Inc. 478,067$626,0000.03%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$16,0000.01%
Atria Wealth Solutions, Inc. 281,700$369,0000.01%
Vivaldi Capital Management LP 17,078$22,0000.01%
OSAIC HOLDINGS, INC. 1,284,481$1,684,0000.00%
Ameritas Advisory Services, LLC 45,302$59,0000.00%
CENTAURUS FINANCIAL, INC. 20,947$27,0000.00%
Summit Trail Advisors, LLC 23,855$31,0000.00%
WEDBUSH SECURITIES INC 27,998$37,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders